SGH
GSK icon

Schonfeld Group Holdings’s GSK GSK Stock Holding History

Schonfeld Group Holdings’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$295K Buy
+5,843
New +$298K 0.19% 163

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Schonfeld Group Holdings's GSK Position: Q4 2015 in Review

Schonfeld Group Holdings opened a new position in GSK (GSK) in Q4 2015: 5,843 shares worth $295K. The stake represents 0.19% of the portfolio and ranks #163 among its holdings.

718 funds tracked by Wall St. Rank hold GSK as of Q4 2015.

  • Schonfeld Group Holdings held 5,843 shares of GSK worth $295K as of Q4 2015.
  • GSK was a new Schonfeld Group Holdings position in Q4 2015.
  • GSK made up 0.19% of Schonfeld Group Holdings's portfolio in Q4 2015, its #163 holding.
  • 718 funds tracked by Wall St. Rank held GSK as of Q4 2015.

Based on Schonfeld Group Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.